Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis

American Journal of Cardiology

Volumn 110, Issue 3, 2012, Pages 420-424

  Crowson, Cynthia S ^a   Matteson, Eric L ^a   Roger, Veronique L ^a   Therneau, Terry M ^a   Gabriel, Sherine E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REYNOLDS RISK SCORE; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84863988953     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.03.044     Document Type: Article

References (30)

1. R.B. D'Agostino Sr, R.S. Vasan, M.J. Pencina, P.A. Wolf, M. Cobain, J.M. Massaro, W.B. Kannel General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
2. A. Gonzalez, H.M. Kremers, C.S. Crowson, K.V. Ballman, V.L. Roger, S.J. Jacobsen, W.M. O'Fallon, S.E. Gabriel Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis 67 2008 64 69
3. E. Myasoedova, C.S. Crowson, H.M. Kremers, V.L. Roger, P.D. Fitz-Gibbon, T.M. Therneau, S.E. Gabriel Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease Ann Rheum Dis 70 2011 482 487
4. H. Pieringer, M. Pichler Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications Q J Med 104 2011 13 26
5. P.M. Ridker, J.E. Buring, N. Rifai, N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
6. H. Maradit Kremers, C.S. Crowson, S.E. Gabriel Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases Rheum Dis Clin North Am 30 2004 819 834
7. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, T.A. Medsger Jr, D.M. Mitchell, D.H. Neustadt, R.S. Pinals, J.G. Schaller, J.T. Sharp, R.L. Wilder, G.G. Hunder The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 1988 315 324
8. E. Myasoedova, C.S. Crowson, H.M. Kremers, T.M. Therneau, S.E. Gabriel Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota 1955-2007 Arthritis Rheum 62 2010 1576 1582
9. S.R. Mascioli, D.R. Jacobs Jr, T.E. Kottke Diagnostic criteria for hospitalized acute myocardial infarction: the Minnesota experience Int J Epidemiol 18 1989 76 83
10. A.K. Bacani, S.E. Gabriel, C.S. Crowson, J.A. Heit, E.L. Matteson Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 64 2012 53 61
11. K.K. Ho, J.L. Pinsky, W.B. Kannel, D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 1993 6A 13A
12. D.R. Cox Some simple approximate tests for Poisson variates Biometrika 40 1953 354 360
13. D.M. Lloyd-Jones Cardiovascular risk prediction: basic concepts, current status, and future directions Circulation 121 2010 1768 1777
14. E.W. Steyerberg, A.J. Vickers, N.R. Cook, T. Gerds, M. Gonen, N. Obuchowski, M.J. Pencina, M.W. Kattan Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 2010 128 138
15. M.J. Pencina, R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 2004 2109 2123
16. G.L. Booth, M.K. Kapral, K. Fung, J.V. Tu Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study Lancet 368 2006 29 36
17. D.E. Weiner, H. Tighiouart, E.F. Elsayed, J.L. Griffith, D.N. Salem, A.S. Levey, M.J. Sarnak The Framingham predictive instrument in chronic kidney disease J Am Coll Cardiol 50 2007 217 224
18. R.L. Coleman, R.J. Stevens, R. Retnakaran, R.R. Holman Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes Diabetes Care 30 2007 1292 1293
19. J.M. Esdaile, M. Abrahamowicz, T. Grodzicky, Y. Li, C. Panaritis, R. du Berger, R. Cote, S.A. Grover, P.R. Fortin, A.E. Clarke, J.L. Senecal Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus Arthritis Rheum 44 2001 2331 2337
20. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
21. M.J. Peters, D.P. Symmons, D. McCarey, B.A. Dijkmans, P. Nicola, T.K. Kvien, I.B. McInnes, H. Haentzschel, M.A. Gonzalez-Gay, S. Provan, A. Semb, P. Sidiropoulos, G. Kitas, Y.M. Smulders, M. Soubrier, Z. Szekanecz, N. Sattar, M.T. Nurmohamed EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 2010 325 331
22. E. Myasoedova, C.S. Crowson, H. Maradit-Kremers, P.D. Fitz-Gibbon, T.M. Therneau, S.E. Gabriel Total cholesterol and LDL levels decrease before rheumatoid arthritis Ann Rheum Dis 69 2010 1310 1314
23. M.J. Peters, A.E. Voskuyl, N. Sattar, B.A. Dijkmans, Y.M. Smulders, M.T. Nurmohamed The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better Int J Clin Pract 64 2010 1440 1443
24. Y.H. Rho, C.P. Chung, A. Oeser, J. Solus, Y. Asanuma, T. Sokka, T. Pincus, P. Raggi, T. Gebretsadik, A. Shintani, C.M. Stein Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis Arthritis Rheum 61 2009 1580 1585
25. S.I. van Leuven, R. Franssen, J.J. Kastelein, M. Levi, E.S. Stroes, P.P. Tak Systemic inflammation as a risk factor for atherothrombosis Rheumatology (Oxford) 47 2008 3 7
26. N. Sattar, I.B. McInnes Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions Curr Opin Rheumatol 17 2005 286 292
27. T. Shah, J.P. Casas, J.A. Cooper, I. Tzoulaki, R. Sofat, V. McCormack, L. Smeeth, J.E. Deanfield, G.D. Lowe, A. Rumley, F.G. Fowkes, S.E. Humphries, A.D. Hingorani Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts Int J Epidemiol 38 2009 217 231
28. J. Listing, A. Strangfeld, J. Kekow, M. Schneider, A. Kapelle, S. Wassenberg, A. Zink Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58 2008 667 677
29. S.L. Westlake, A.N. Colebatch, J. Baird, P. Kiely, M. Quinn, E. Choy, A.J. Ostor, C.J. Edwards The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review Rheumatology (Oxford) 49 2010 295 307
30. J.M. Davis III, H. Maradit Kremers, C.S. Crowson, P.J. Nicola, K.V. Ballman, T.M. Therneau, V.L. Roger, S.E. Gabriel Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 56 2007 820 830